Boost Serotonin in the Brain: Targeting TPH2 Enzymes to Treat Depression
Depression affects over 120 million people worldwide, carrying a heavy burden of disability, mortality, and cost. While medications like SSRIs have provided relief for many, most patients fail to achieve full remission. After 30 years with few advances in pharmaceutical options, it may be time to rethink our approach to treating depression. Exciting new research …
